Peter Meintjes
Algemeen Directeur bij PACIFIC EDGE LIMITED
Vermogen: 24 192 $ op 31-05-2024
Profiel
Peter Meintjes is currently the Chief Executive Officer at Pacific Edge Ltd.
He is also a Director at Pacific Edge Diagnostics USA Ltd.
and Pacific Edge Pty Ltd.
Previously, he served as the Chief Executive Officer at Omixon Biocomputing Kft and the Chief Commercial Officer at Transplant Genomics, Inc. He holds a doctorate degree from Auckland University, which he obtained in 2008.
He also completed his undergraduate and graduate studies at Auckland University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PACIFIC EDGE LIMITED
0.05% | 25-10-2023 | 386 016 ( 0.05% ) | 24 192 $ | 31-05-2024 |
Actieve functies van Peter Meintjes
| Bedrijven | Functie | Begin |
|---|---|---|
| PACIFIC EDGE LIMITED | Algemeen Directeur | 17-01-2022 |
Pacific Edge Diagnostics USA Ltd.
 Pacific Edge Diagnostics USA Ltd. Medical/Nursing ServicesHealth Services Part of Pacific Edge Ltd., Pacific Edge Diagnostics USA Ltd. manages and operates laboratories used for the detection of bladder cancer. The company is based in Hummelstown, PA. Jackie Walker has been the CEO of the company since 2012. | Directeur/Bestuurslid | - |
| Pacific Edge Pty Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Peter Meintjes
| Bedrijven | Functie | Einde |
|---|---|---|
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Corporate Officer/Principal | 01-03-2021 |
Omixon Biocomputing Kft
 Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Algemeen Directeur | 20-04-2020 |
Opleiding van Peter Meintjes
| Auckland University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PACIFIC EDGE LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Health Technology |
Pacific Edge Diagnostics USA Ltd.
Pacific Edge Diagnostics USA Ltd. Medical/Nursing ServicesHealth Services Part of Pacific Edge Ltd., Pacific Edge Diagnostics USA Ltd. manages and operates laboratories used for the detection of bladder cancer. The company is based in Hummelstown, PA. Jackie Walker has been the CEO of the company since 2012. | Health Services |
| Pacific Edge Pty Ltd. | |
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Health Technology |
